B. SELECT COMMITTEE ATTENDANCE, WORK,
PUBLICATIONS ETC
26. Science and Technology
The Committee was nominated on 14 July 1997.
It had 11 Members and held 44 meetings.
|
Members | Meetings attended
|
|
Clark, Dr Michael (Chairman) | 39
|
Ashdown, Sir Paddy (added, 15.5.00) | 4
|
Beard, Mr Nigel (discharged, 20.3.00) | 16
|
Curtis-Thomas, Mrs Claire | 20
|
Gibson, Dr Ian | 41
|
Iddon, Dr Brian (added, 20.3.00) | 25
|
Jackson, Mr Robert | 13
|
Jones, Dr Lynn | 33
|
Jones, Mr Nigel (discharged, 15.5.00) | 6
|
Kumar, Dr Ashok | 30
|
Taylor, Mr Ian | 14
|
Turner, Dr Desmond | 38
|
Williams, Dr Alan W | 22
|
|
Overall attendance: | 62.2%
|
Number of Members added: | 2
|
Number of Members discharged: | 2
|
Turnover of membership during the Session: |
18 % |
|
Staff
Clerk of the Committee: Mrs Jessica Mulley, Senior Clerk (Band
A2) (until 31.10.00), Ms Philippa Helme, Deputy Principal Clerk
(Senior Structure Band 2) (from 31.10.00).
Second Clerk: Mr David Doig, Deputy Principal Clerk (Senior Structure
Band 2) (seconded from Public Bill Office from 2.2.00 until 29.3.00),
Mr Geoffrey Farrar, Assistant Clerk (Band A3) (from 2.10.00).
Committee Specialist: Dr Guy Rickett (Band B1).
Committee Assistant: Mrs Leonie Nugent, Higher Executive Officer
(Band B2).
Secretary: Mrs Anne Browning, Secretary (Band D1).
Specialist Advisers during the Session
Professor Janet Askham, Professor Michael Brady, Professor
Derek Burke, Professor Michel Coleman, Dr Helena Earl, Professor
Michael Elves, Professor Peter Liss, Dr John Pyle.
Witnesses
Oral evidence was given during the Session by the following categories
of witnesses:
Number of appearances by:
| |
Cabinet Ministers
| 1 |
Other Ministers
| 1 |
Ministerial appearances by Members of the House of Lords
| 4 |
Number of appearances by officials from, or representatives of
| |
Office of Science and Technology
| 8 |
other departments
| 8 |
comprising: Ministry of Agriculture, Fisheries and Food
| 2 |
Department of the Environment, Transport and the Regions
| 2 |
Department of Health
| 4 |
public bodies and non-Ministerial departments
| 8 |
comprising: Biological and Biological Sciences Research Council
| 2 |
Medical Research Council
| 6 |
Appearances by other witnesses
| 71 |
Overseas Visits
Date | Destination
| Members
| Staff |
Purpose |
Cost |
2-6.4.00 | USA and Canada
| 5 |
2 A
| Inquiry into Cancer Research-A Fresh Look
| £ 27,630.00
|
21.5.00 | Berlin
| 3* |
| Eureka Conference
| £1,775.42
|
6-7.6.00 | Helsinki
| 5 |
2 A
| Inquiry into Cancer Research-A Fresh Look
| £7,306.28
|
13.7.00Cancelled | Paris
| | | Inquiry into Cancer Research-A Fresh Look
| £361.37
|
A Includes 1
specialist adviser
* Travel in a representative capacity
Visits to European Institutions
None.
UK Visits
Date |
Destination
| Members
| Staff |
Purpose |
Cost |
10.4.00 | Royal Society, London
| 1* |
1 | Tsunami Conference
| £0.00
|
17.5.00 | Institute of Cancer Research and Royal Marsden Hospital, Sutton
| 8 |
3 A
| Inquiry into Cancer ResearchA Fresh Look
| £536.60
|
20.6.00 | Queen's University and City Hospital, Belfast
| 4 |
3 A
| Inquiry into Cancer ResearchA Fresh Look
| £2,105.36
|
29.6.00 | Paterson Institute and Christie Hospital, Manchester
| 5 |
2 | Inquiry into Cancer ResearchA Fresh Look
| £454.44
|
4.7.00 | Cancer Research Campaign Beatson Laboratories and Western Infirmary, Glasgow
| 3 |
3 A
| Inquiry into Cancer ResearchA Fresh Look
| £2,140.79
|
5.7.00 | University of Newcastle MedicalSchool and Northern Centre for Cancer Treatment, Newcastle
| 3 |
3 A
| Inquiry into Cancer ResearchA Fresh Look
| £2,140.79
|
A Includes 1 specialist
adviser
* Travel in a representative capacity
Reports and Minutes of Evidence
Title | HC No. (1999-2000)
| Date of publication
| No. of pages
| Sale price
| Government reply
|
Fourth Report, 1998-99: The Regulation of the Biotechnology Industry
| 535 |
13.12.99 |
40 | £8
| Not required
|
First Report: The Year 2000Computer Compliance: Follow-Up
| 37 |
9.12.99 |
16 | £4.30
| Not required
|
Second Report: Engineering and Physical Sciences Based Innovation
| 195-I |
9.2.00 |
59 | £9.70
| Received 18.4.00: published as First Special Report, Session 1999-2000
|
Appendices to the Minutes of Evidence: Engineering and Physical Sciences Based Innovation
| 195-II
| 9.2.00
| 178 |
£18.00
| Not applicable
|
Third Report: The Scientific Advisory System: Diabetes and Driving Licences
| 206-I |
7.3.00 |
26 | £6.50
| Cm 4723, published 3.5.00
|
Minutes of Evidence and Appendices: The Scientific Advisory System: Diabetes and Driving Licences
| 206-II
| 7.3.00
| 79 |
£11.50
| Not applicable
|
Fourth Report: Glaxo Wellcome and SmithKline Beecham
| 207-I |
11.4.00 |
13 | £4.30
| Not required
|
Minutes of Evidence and Appendices: Glaxo Wellcome and SmithKline Beecham
| 207-II
| 11.4.00
| 28 |
£7.00 |
Not applicable
|
Fifth Report: Government Expenditure on Research and Development: The Forward Look
| 196-I |
19.4.00 |
45 | £8.80
| Received 4.7.00: published as an Appendix to the Committee's Seventh Report, Session 1999-2000
|
Appendices to the Minutes of Evidence: Government Expenditure on Research and Development: The Forward Look
| 196-II
| 19.4.00
| 55 |
£9.70 |
Not applicable
|
Sixth Report: Cancer ResearchA Fresh Look
| 332-I |
27.7.00 |
87 | £12.50
| Cm 4928, published 17.11.00
|
Appendices to the Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-II
| 28.7.00
| 153 |
£14.95
| Not applicable
|
Seventh Report: The Government's Expenditure on Research and Development: The Forward LookThe Government's Reply
| 723 |
16.8.00 |
18 | £5.00
| Received 13.11.00: published as Third Special Report, Session 1999-2000
|
First Special Report: Government Response to the Second Report on Engineering and Physical Sciences Based Innovation
| 451 |
8.5.00 |
22 | £5.50
| Not applicable
|
Second Special Report: Joint Working with the Lords Science and Technology Committee
| 980 |
16.11.00 |
3 | £1.45
| Not applicable
|
Third Special Report: Government Response to the Seventh Report on the Government's Expenditure on Research and Development: The Forward LookThe Government's Reply
| 981 |
23.11.00 |
12 | £3.40
| Not applicable
|
Minutes of Evidence: The Director General of the Research Councils
| 81-i |
17.1.00 |
15 | £4.75
| Not applicable
|
Minutes of Evidence: The Proposed New Synchrotron Facility
| 82-i |
19.1.00 |
22 | £5.50
| Not applicable
|
Minutes of Evidence: The Proposed New Synchrotron Facility
| 82-ii |
11.2.00 |
9 | £3.40
| Not applicable
|
Minutes of Evidence: Government Expenditure on Research and Development: The Forward Look
| 196-i |
28.2.00 |
20 | £5.50
| Not applicable
|
Minutes of Evidence: Government Expenditure on Research and Development: The Forward Look
| 196-ii
| 15.3.00
| 20 |
£5.50 |
Not applicable
|
Minutes of Evidence: EQUAL (Extend Quality Life)
| 245-i |
22.3.00 |
11 | £4.00
| Not applicable
|
Minutes of Evidence: Government Expenditure on Research and Development: The Forward Look
| 196-iii
| 29.3.00
| 12 |
£4.00 |
Not applicable
|
Minutes of Evidence: EQUAL (Extend Quality Life)
| 245-ii
| 31.3.00
| 16 |
£4.70 |
Not applicable
|
Minutes of Evidence: EQUAL (Extend Quality Life)
| 245-iii
| 31.3.00
| 12 |
£4.00 |
Not applicable
|
Minutes of Evidence: EQUAL (Extend Quality Life)
| 245-iv
| 26.4.00
| 9 |
£3.40 |
Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-i |
27.4.00 |
25 | £6.20
| Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-ii
| 23.5.00
| 24 |
£4.00 |
Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-iii
| 23.5.00
| 15 |
£6.70 |
Not applicable
|
Minutes of Evidence: The Proposed New Synchrotron Facility
| 82-iii
| 24.5.00
| 13 |
£4.00 |
Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-iv
| 15.6.00
| 62 |
£10.60
| Not applicable
|
Minutes of Evidence: Scientific Advisory System: Scientific Advice on Climate Change
| 285-i |
15.6.00 |
16 | £4.75
| Not applicable
|
Minutes of Evidence: Are We Realising Our Potential?
| 466-i |
28.6.00 |
10 | £3.40
| Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-v |
4.7.00 |
19 | £5.50
| Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-vi
| 4.7.00
| 21 |
£5.50 |
Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-vii
| 19.7.00
| 11 |
£3.40 |
Not applicable
|
Minutes of Evidence: Cancer ResearchA Fresh Look
| 332-viii
| 3.8.00
| 60 |
£10.60
| Not applicable
|
Minutes of Evidence: Are We Realising Our Potential?
| 466-ii
| 3.8.00
| 12 |
£4.00 |
Not applicable
|
Minutes of Evidence: Are We Realising Our Potential?
| 466-iii
| 14.8.00
| 8 |
£3.40 |
Not applicable
|
Minutes of Evidence: Are We Realising Our Potential?
| 466-iv
| 14.8.00
| 21 |
£5.50 |
Not applicable
|
Minutes of Evidence: Are We Realising Our Potential?
| 466-v |
14.8.00 |
16 | £4.75
| Not applicable
|
Minutes of Evidence: The Science Budget
| 898-i |
30.11.00 |
11 | £4.00
| Not applicable
|
Memoranda: The Proposed New Synchrotron Facility
| 82 |
27.6.00 |
49 | £9.70
| Not applicable
|
Memoranda: Scientific Advisory System
| 465 |
10.10.00 |
154 | £17.00
| Not applicable
|
Government replies to Reports for Session 1998-99
Reply to the Committee's First Report:
Scientific Advisory System: Genetically Modified Foods,
published as Cm 4527 (26.11.99).
Reply to the Committee's Third Report: Scientific Advisory
System: Mobile Phones and Health, published as Cm 4557 (16.12.99).
Minutes of Proceedings
The Minutes of Proceedings of the Committee for Session 1998-99
were published on 21.12.99 as HC914, Session 1998-99. The Minutes
of Proceedings of the Committee for Session 1999-2000 were published
on 22.12.00 as HC793, Session 1999-2000.
Divisions
None.
Debates
The following Reports were debated in Westminster Hall:
First Report, Session 1998-99, Scientific Advisory System:
Genetically Modified Foods,13.1.00
Second Report, Session 1999-2000, Engineering and Physical
Sciences Based Innovation,11.5.00
Oral Evidence
Oral evidence was taken at 28 of the Committee's 44 meetings.
On none of these occasions was evidence taken partly or wholly
in private.
Inquiry | No. of oral evidence sessions
|
Government Expenditure on Research and Development: The Forward Look
| 3 |
Scientific Advisory System: Scientific Advice on Climate Change*
| 1 |
EQUAL (Extend Quality Life)*
| 4 |
Cancer ResearchA Fresh Look
| 8 |
Are We Realising Our Potential?*
| 5 |
The Director General of the Research Councils
| 1 |
The Proposed New Synchrotron Facility
| 3 |
Glaxo Wellcome and SmithKline Beecham
| 1 |
The Science Budget* |
1 |
Corus plc* | 3
|
Total | 30
|
* The Committee did not complete these inquiries
in Session 1999-2000
|